Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
Nicola Silvestris, Tindara Franchina, Marco Gallo, Antonella Argentiero, Angelo Avogaro, Giuseppe Cirino, Annamaria Colao, Romano Danesi, Graziano Di Cianni, Stella D’Oronzo, Antongiulio Faggiano, Stefano Fogli, Dario Giuffrida, Stefania Gori, Nicola Marrano, Rossella Mazzilli, Matteo Monami, Monica Montagnani, L. Morviducci, Annalisa Natalicchio, Alberto Ragni, Valerio Renzelli, Antonio Russo, Laura Sciacca, Enzo Tuveri, Maria Chiara Zatelli, Francesco Giorgino, Saverio Cinieri
Abstract
•This multidisciplinary consensus position paper focuses on identifying a novel specialty field, ‘diabeto-oncology’.•A critical overview of cancer and diabetes co-management is provided to implement integrated care plans to support patients.•The author panel encompasses a multidisciplinary group of experts from different Italian scientific societies. Cancer management has significantly evolved in recent years, focusing on a multidisciplinary team approach to provide the best possible patient care and address the various comorbidities, toxicities, and complications that may arise during the patient’s treatment journey. The co-occurrence of diabetes and cancer presents a significant challenge for health care professionals worldwide. Management of these conditions requires a holistic approach to improve patients’ overall health, treatment outcomes, and quality of life, preventing diabetes complications and cancer treatment side-effects. In this article, a multidisciplinary panel of experts from different Italian scientific societies provide a critical overview of the co-management of cancer and diabetes, with an increasing focus on identifying a novel specialty field, ‘diabeto-oncology’, and suggest new co-management models of cancer patients with diabetes to improve their care. To better support cancer patients with diabetes and ensure high levels of coordinated care between oncologists and diabetologists, ‘diabeto-oncology’ could represent a new specialized field that combines specific expertise, skills, and training. Cancer management has significantly evolved in recent years, focusing on a multidisciplinary team approach to provide the best possible patient care and address the various comorbidities, toxicities, and complications that may arise during the patient’s treatment journey. The co-occurrence of diabetes and cancer presents a significant challenge for health care professionals worldwide. Management of these conditions requires a holistic approach to improve patients’ overall health, treatment outcomes, and quality of life, preventing diabetes complications and cancer treatment side-effects. In this article, a multidisciplinary panel of experts from different Italian scientific societies provide a critical overview of the co-management of cancer and diabetes, with an increasing focus on identifying a novel specialty field, ‘diabeto-oncology’, and suggest new co-management models of cancer patients with diabetes to improve their care. To better support cancer patients with diabetes and ensure high levels of coordinated care between oncologists and diabetologists, ‘diabeto-oncology’ could represent a new specialized field that combines specific expertise, skills, and training.